BFRI · Biofrontera Inc. Common Stock
View on chartInsiders & Stakes
| Hermann Luebbert Executive Chairman | ▲ Buy | Option Exercise | 352,711 Shares held | 7/28/2026 | View profile |
| Eugene Frederick Leffler Chief Financial Officer | ▲ Buy | Option Exercise | 206,250 Shares held | 7/28/2026 | View profile |
| Erica L. Monaco Chief Executive Officer | ▲ Buy | Option Exercise | 133,025 Shares held | 5/18/2023 | View profile |
Transaction History
| Eugene Frederick Leffler | ▲ Buy | Option Exercise | 31,250 | — | 7/28/2026 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 62,500 | — | 7/28/2026 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 137,500 | — | 3/5/2026 |
| Eugene Frederick Leffler | ▲ Buy | Option Exercise | 87,500 | — | 3/5/2026 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 137,500 | — | 9/10/2025 |
| Eugene Frederick Leffler | ▲ Buy | Option Exercise | 87,500 | — | 9/10/2025 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 4,771 | — | 5/18/2024 |
| Erica L. Monaco | ▲ Buy | Option Exercise | 76,336 | — | 5/18/2023 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 95,420 | — | 5/18/2023 |
| Hermann Luebbert | ▲ Buy | Option Exercise | 113,379 | — | 8/22/2022 |
| Erica L. Monaco | ▲ Buy | Option Exercise | 56,689 | — | 7/1/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Biofrontera Q2 2026 Earnings Call Discusses Results
Biofrontera held its Q2 2026 earnings conference call, where management discussed the quarter's results and future plans. The call was broadcast on Benzinga and provided updates on revenue, expenses, and guidance. The stock is trading near the lower end of its 52‑week range and close to the $1.05 support level, which may influence short‑term market reactions.
Biofrontera Q2 2026 Earnings Call Discusses Results. Biofrontera held its Q2 2026 earnings conference call, where management discussed the quarter's results and future plans. The call was broadcast on Benzinga and provided updates on revenue, expenses, and guidance. The stock is trading near the lower end of its 52‑week range and close to the $1.05 support level, which may influence short‑term market reactions.